Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02943837

EUS-guided Fine Needle Aspiration (EUS-FNA) Versus EUS-guided Fine Needle Biopsy (EUS-FNB) for Diagnosis of Subepithelial Tumors

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Asan Medical Center · Academic / Other
Sex
All
Age
19 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Background: Preoperative pathologic diagnosis of subepithelial tumor (SET) can improve clinical decision making. Although EUS-guided fine needle aspiration (FNA) is currently considered the standard method for sampling SET, its diagnostic yield is generally suboptimal. EUS-guided fine needle biopsy (FNB) of SET is safe and feasible with adequate histology obtained. Objective: To compare the diagnostic accuracy of EUS-FNA and EUS-FNB.

Conditions

Interventions

TypeNameDescription
PROCEDUREDevice: 22G FNA needle
PROCEDUREDevice: 20G FNB needle

Timeline

Start date
2016-10-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2016-10-25
Last updated
2021-01-13

Source: ClinicalTrials.gov record NCT02943837. Inclusion in this directory is not an endorsement.

EUS-guided Fine Needle Aspiration (EUS-FNA) Versus EUS-guided Fine Needle Biopsy (EUS-FNB) for Diagnosis of Subepithelia (NCT02943837) · Clinical Trials Directory